ArticleScientific reports2025
Morphology dependent antibacterial activity of zinc oxide nanoparticles against clinically relevant bacteria.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Antioxidant and antibacterial properties of transition metals and metal oxides for medical uses: mechanisms, design strategies, and biomedical perspectives.Nanoscale advances · 2026Review
- Organ-on-chip (OoC) and nano-biomaterials: next generation of precision oral and dental healthcare research.Journal of nanobiotechnology · 2026Review
- Antibacterial and biocompatibility potentials of zinc oxide quantum dots via Nd: YAG laser ablation.Scientific reports · 2026Article
- Marine Algae as Sustainable Platforms for the Green Synthesis of Metal Nanoparticles.ACS omega · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study focuses on the antibacterial activity of ZnO nanoparticles, evaluating variations based on morphology. Interest in ZnO nanoparticles arises from their high surface-to-volume ratio that enables effective interaction with bacterial cells. Their antibacterial properties depend on size and nanostructure, with enhanced activity attributed to increased surface area, promoting maximum contact with microbial membranes, cellular damage, and growth inhibition. Zinc oxide (ZnO) nanoparticles with two distinct shapes-ellipsoidal nanorods (Z1) and 3D microspheres (Z2)-were synthesized using a simple, template-free aqueous precipitation method. Zinc nitrate and hexamethylenetetramine (HMT) served as starting materials. The nanoparticles were characterized using scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FT-IR), and thermogravimetric analysis (TGA). The point of zero charge (PZC) was determined by the salt addition method. SEM images showed that particle shape changed with reaction time. XRD confirmed a hexagonal wurtzite crystal structure, with average crystallite sizes of 22.09 nm for Z1 and 27.18 nm for Z2. FT-IR spectra showed Zn-O bond vibrations between 540 and 411 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.